Clinical trial

Vascular Improvement With Olmesartan Medoxomil Study

NCT00772499

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-11-01

PhasePHASE4

Study timeline

Study start (unknown)2002-11-01Date precision: month

Registry last updated2008-10-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressureDRUG

atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressureDRUG

Sponsors & collaborators

Daiichi Sankyolead sponsor

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00772499 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.